ASMTL | Acetylserotonin O-methyltransferase-like | | | | | | Expressed in all |
CD99 | CD99 molecule | CD markers Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
RAB9A | RAB9A, member RAS oncogene family | | | | | | Expressed in all |
TXLNG | Taxilin gamma | | | | | | Expressed in all |
SH3KBP1 | SH3-domain kinase binding protein 1 | Cytoskeleton related proteins
| | | | | Expressed in all |
PRDX4 | Peroxiredoxin 4 | Cancer-related genes Enzymes Predicted secreted proteins
| | | | | Expressed in all |
CASK | Calcium/calmodulin-dependent serine protein kinase (MAGUK family) | Disease related genes Enzymes Potential drug targets Predicted membrane proteins
| | | | | Expressed in all |
USP11 | Ubiquitin specific peptidase 11 | Enzymes Plasma proteins Predicted secreted proteins
| | | | | Expressed in all |
WAS | Wiskott-Aldrich syndrome | Cancer-related genes Disease related genes
| | | | | Mixed |
PQBP1 | Polyglutamine binding protein 1 | Disease related genes
| | | | | Expressed in all |
PRAF2 | PRA1 domain family, member 2 | Predicted membrane proteins
| | | | | Expressed in all |
SYP | Synaptophysin | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enriched |
GSPT2 | G1 to S phase transition 2 | | | | | | Expressed in all |
HUWE1 | HECT, UBA and WWE domain containing 1, E3 ubiquitin protein ligase | Cancer-related genes Disease related genes Predicted membrane proteins
| | | | | Expressed in all |
MSN | Moesin | Cancer-related genes Cytoskeleton related proteins Plasma proteins
| | | | | Expressed in all |
NONO | Non-POU domain containing, octamer-binding | Cancer-related genes Disease related genes Plasma proteins Transcription factors
| | | | | Expressed in all |
TAF1 | TAF1 RNA polymerase II, TATA box binding protein (TBP)-associated factor, 250kDa | Cancer-related genes Disease related genes Enzymes Potential drug targets Transcription factors
| | | | | Expressed in all |
PHKA1 | Phosphorylase kinase, alpha 1 (muscle) | Disease related genes
| | | | | Tissue enhanced |
CSTF2 | Cleavage stimulation factor, 3' pre-RNA, subunit 2, 64kDa | Plasma proteins
| | | | | Expressed in all |
BTK | Bruton agammaglobulinemia tyrosine kinase | Disease related genes Enzymes Plasma proteins Potential drug targets
| | | | | Tissue enhanced |
HNRNPH2 | Heterogeneous nuclear ribonucleoprotein H2 (H') | | | | | | Expressed in all |
MORF4L2 | Mortality factor 4 like 2 | Plasma proteins
| | | | | Expressed in all |
MORC4 | MORC family CW-type zinc finger 4 | Cancer-related genes
| | | | | Tissue enhanced |
PSMD10 | Proteasome (prosome, macropain) 26S subunit, non-ATPase, 10 | | | | | | Expressed in all |
UPF3B | UPF3 regulator of nonsense transcripts homolog B (yeast) | Disease related genes
| | | | | Expressed in all |
LAMP2 | Lysosomal-associated membrane protein 2 | CD markers Disease related genes Plasma proteins Potential drug targets Predicted membrane proteins Transporters
| | | | | Expressed in all |
CUL4B | Cullin 4B | Cancer-related genes Disease related genes Plasma proteins
| | | | | Expressed in all |
SASH3 | SAM and SH3 domain containing 3 | | | | | | Tissue enhanced |
AIFM1 | Apoptosis-inducing factor, mitochondrion-associated, 1 | Disease related genes Mitochondrial proteins Plasma proteins Predicted membrane proteins
| | | | | Expressed in all |
HPRT1 | Hypoxanthine phosphoribosyltransferase 1 | Disease related genes Enzymes FDA approved drug targets Plasma proteins
| | | | | Expressed in all |
FHL1 | Four and a half LIM domains 1 | Disease related genes Plasma proteins Predicted secreted proteins
| | | | | Expressed in all |
HTATSF1 | HIV-1 Tat specific factor 1 | | | | | | Expressed in all |
MAGEC1 | Melanoma antigen family C, 1 | Cancer-related genes Plasma proteins
| | | | | Tissue enriched |
FMR1NB | Fragile X mental retardation 1 neighbor | Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enriched |
NSDHL | NAD(P) dependent steroid dehydrogenase-like | Disease related genes Enzymes Potential drug targets Predicted membrane proteins
| | | | | Expressed in all |
ZNF185 | Zinc finger protein 185 (LIM domain) | Cytoskeleton related proteins Plasma proteins
| | | | | Expressed in all |
PNMA5 | Paraneoplastic Ma antigen family member 5 | | | | | | Group enriched |
DUSP9 | Dual specificity phosphatase 9 | Enzymes
| | | | | Group enriched |
BCAP31 | B-cell receptor-associated protein 31 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Expressed in all |
SSR4 | Signal sequence receptor, delta | Plasma proteins Predicted membrane proteins
| | | | | Expressed in all |
ARHGAP4 | Rho GTPase activating protein 4 | | | | | | Expressed in all |
NAA10 | N(alpha)-acetyltransferase 10, NatA catalytic subunit | Disease related genes Enzymes Potential drug targets
| | | | | Expressed in all |
IRAK1 | Interleukin-1 receptor-associated kinase 1 | Enzymes
| | | | | Expressed in all |
FLNA | Filamin A, alpha | Disease related genes Plasma proteins
| | | | | Expressed in all |
EMD | Emerin | Disease related genes Predicted membrane proteins
| | | | | Expressed in all |
G6PD | Glucose-6-phosphate dehydrogenase | Cancer-related genes Disease related genes Enzymes Plasma proteins Potential drug targets
| | | | | Expressed in all |
CTAG1A | Cancer/testis antigen 1A | Cancer-related genes
| | | | | Tissue enriched |
DKC1 | Dyskeratosis congenita 1, dyskerin | Disease related genes Plasma proteins
| | | | | Expressed in all |
CMC4 | C-x(9)-C motif containing 4 | Disease related genes Mitochondrial proteins
| | | | | Expressed in all |